Literature DB >> 22967896

Clarification of the C-terminal proteolytic processing site of human Amphiregulin.

Kelly S Levano1, Paraic A Kenny.   

Abstract

Amphiregulin, like other ErbB ligands, is synthesized as a pro-protein which requires cleavage at the cell surface to release the active signaling domain. Prior studies using a variety of approaches have not yielded a consensus about the precise cleavage site. Here we report the purification and protein sequencing of the cell-associated human Amphiregulin stalk which remains following cleavage of the signaling domain. These data indicate that human Amphiregulin is cleaved at Lysine 187, a site homologous to the cleavage site reported in the mouse protein and distinct from the Lysine 184 site previously reported for the human protein.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22967896     DOI: 10.1016/j.febslet.2012.07.078

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.

Authors:  Qin Xu; Mingang Ying; Guilin Chen; Ang Lin; Yunqing Xie; Noriyuki Ohara; Dongmei Zhou
Journal:  Tumour Biol       Date:  2014-05-04

2.  Anti-tumor efficacy of an MMAE-conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer.

Authors:  Kristopher A Lofgren; Sreeja Sreekumar; E Charles Jenkins; Kyle J Ernzen; Paraic A Kenny
Journal:  Antib Ther       Date:  2021-11-10

3.  Pan-cancer distribution of cleaved cell-surface amphiregulin, the target of the GMF-1A3 antibody drug conjugate.

Authors:  Kristopher A Lofgren; Nicolette C Reker; Sreeja Sreekumar; Paraic A Kenny
Journal:  Antib Ther       Date:  2022-08-01

4.  Identification of Important Genes of Keratoconus and Construction of the Diagnostic Model.

Authors:  Lin Wang; Yuqing Wang; Juan Liu; Wencheng Zhao
Journal:  Genet Res (Camb)       Date:  2022-09-12       Impact factor: 1.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.